From: Prognostic value of miR-96 in patients with acute myeloid leukemia
Characteristics | Cases | miRc96 expression level | x 2 | p | ||
---|---|---|---|---|---|---|
Low expression | High expression | |||||
Sex | Male | 42 | 28 | 14 | 0.374 | 0.541 |
Female | 44 | 32 | 12 | |||
Age | <60 | 64 | 46 | 18 | 0.527 | 0.468 |
≥60 | 22 | 14 | 8 | |||
WBC | <10 | 26 | 11 | 15 | 13.323 | 0.000* |
≥10 | 60 | 49 | 11 | |||
HGB | <80 | 54 | 42 | 12 | 4.415 | 0.036* |
≥80 | 32 | 18 | 14 | |||
PLT | <50 | 48 | 38 | 10 | 4.550 | 0.033* |
≥50 | 38 | 22 | 16 | |||
Blast in BM | <50% | 37 | 21 | 16 | 5.212 | 0.022* |
≥50% | 49 | 39 | 10 | |||
FAB subtype | M1/M2 | 35 | 25 | 10 | 0.791 | 0.673 |
M4/M5 | 47 | 33 | 14 | |||
Other | 4 | 2 | 2 | |||
Cytogenitics | Favorable | 12 | 7 | 5 | 0.516 | 0.776 |
Intermediate | 39 | 26 | 13 | |||
Unfavorable | 14 | 10 | 4 | |||
Complete Remission | Y | 42 | 28 | 14 | 1.551 | 0.213 |
N | 30 | 24 | 6 |